Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zentrale Insulinsensitivität Bei Personen Mit Typ-2-Diabetes Sowie Bei Personen Mit erhöhtem Risiko für Die Entwicklung Von Typ-2-Diabetes

NCT05856877 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05856877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05856877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zentrale Insulinsensitivität Bei Personen Mit Typ-2-Diabetes Sowie Bei Personen Mit erhöhtem Risiko für Die Entwicklung Von Typ-2-Diabetes
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Unknown status
Start date
May 26, 2023
Completion date
December 31, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central insulin resistance, diabetes mellitus, type 2, prediabetes